23085760Doçi CL, Zhou G, Lingen MWOncogeneGene Expression Regulation, Neoplastic; Nuclear Proteins; RNA Processing, Post-Transcriptional; Thrombospondin 1; Tumor Suppressor Proteins3' Untranslated Regions; Animals; Cell Line; Cell Nucleus; Cell Proliferation; Female; Humans; Mice; Neovascularization, Pathologic; Phenotype; Protein Binding; Ribonucleoproteins; RNA, MessengerThe novel tumor suppressor NOL7 post-transcriptionally regulates thrombospondin-1 expression. Oncogene. 2013 Sep 12; 32(37):4377-86.Oncogene2012-10-22T00:00:002012The novel tumor suppressor NOL7 post-transcriptionally regulates thrombospondin-1 expression.prns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000818Living Beings1457265180.249624AnimalsD002467Anatomy2525790.827191Cell NucleusD009389Disorders1303520.823558Neovascularization, PathologicD005260Physiology1992444050.191167FemaleD011485PhenomenaPhysiology42014540.739266Protein BindingD012261Chemicals & Drugs26380.979633RibonucleoproteinsD012323Physiology451050.895827RNA Processing, Post-TranscriptionalD006801Living Beings2262862810.130052HumansD049109Physiology43515710.639735Cell ProliferationD019700Chemicals & Drugs18210.990047Thrombospondin 1D020413Chemicals & Drugs64920.966733' Untranslated RegionsD051379Living Beings980113130.368397MiceD012333Chemicals & Drugs51619750.640012RNA, MessengerD025521Chemicals & Drugs1482790.844953Tumor Suppressor ProteinsD002460Anatomy54024660.697085Cell LineD009687Chemicals & Drugs2646940.701812Nuclear ProteinsD010641Physiology64723750.615854PhenotypeD015972Physiology31511960.666181Gene Expression Regulation, NeoplasticPathologyUniversity of ChicagoMark W.Lingen22tnDKQbOfnamXNnYUHhvWD+6g==Mark W. Lingen41.78927490000000-87.60125000000000864Lingen, Mark W.Professortrue1ProfessorProfessorAuthorship 6840520.11320.11321authors10.2518has subject area